Suchergebnisse - "Colafigli, Gioia"

PubPharm (119)

1

Circulating cell-free DNA for target quantification in hematologic malignancies : Validation of a protocol to overcome pre-analytical biases

enthalten in: Hematological oncology | 2023

von Soscia, R. | Della Starza, I. | De Novi, L. | +23

2

Circulating cell‐free DNA for target quantification in hematologic malignancies : Validation of a protocol to overcome pre‐analytical biases

enthalten in: Hematological Oncology | 2023

von Soscia, R. | Della Starza, I. | Novi, L. | +23

3

Immunomodulatory Effects of IFNα on T and NK Cells in Chronic Myeloid Leukemia Patients in Deep Molecular Response Preparing for Treatment Discontinuation

enthalten in: Journal of clinical medicine | 2022

von Puzzolo, M. | Breccia, M. | Mariglia, P. | +7

4

Future Management of Chronic Myeloid Leukemia : From Dose Optimization to New Agents

enthalten in: Current cancer drug targets | 2022

von Breccia, M. | Scalzulli, E. | Pepe, S. | +2

5

Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients

enthalten in: Expert review of hematology | 2022

von Breccia, M. | Scalzulli, E. | Pepe, S. | +4

6

Future Management of Chronic Myeloid Leukemia: From Dose Optimization to New Agents

enthalten in: Current cancer drug targets | 2022

von Breccia, M. | Scalzulli, E. | Pepe, S. | +2

7

Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials : a real-life cohort observational study

enthalten in: Acta oncologica (Stockholm, Sweden) | 2021

von Stagno, F. | Breccia, M. | Annunziata, M. | +24

8

Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure : a single center experience

enthalten in: Leukemia & lymphoma | 2021

von Pepe, S. | Scalzulli, E. | Colafigli, G. | +7

9

Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab

enthalten in: Annals of hematology | 2021

von Di Prima, A. | Botticelli, A. | Scalzulli, E. | +7

10

Asciminib : an investigational agent for the treatment of chronic myeloid leukemia

enthalten in: Expert opinion on investigational drugs | 2021

von Breccia, M. | Colafigli, G. | Scalzulli, E. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]